Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia
Clinical trial NCT03591744 · WITHDRAWN
Trial details
- NCT number
- NCT03591744
- Sponsor
- City of Hope Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2019-10-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.